Pharma & Biotech

NuCana plc faces persistent selling pressure following a substantial reverse stock split, with the oncology-focused company releasing a new investor...

A significant regulatory milestone achieved by Mainz-based biotechnology firm BioNTech in late August has reignited investor optimism. The U.S. Food...

While reporting improved quarterly figures, biotechnology firm Rallybio finds itself in a precarious battle for its stock market survival. The...

Immunocore Holdings is demonstrating why it remains a compelling story within the biotech sector. The company's recent quarterly performance, underpinned...

Neurocrine Biosciences shares are demonstrating remarkable resilience in a biotech sector often characterized by extreme volatility. The neuropharmaceutical company has...

The biotechnology sector remains a high-stakes environment, and Design Therapeutics currently embodies this volatility. Recent developments surrounding the company's innovative...

The biotechnology sector is inherently risky, but Nautilus Biotechnology appears to be pushing those risks to the extreme. A seemingly...

A significant liquidity event is unfolding for Cellectar Biosciences as a 61-day lock-up restriction on insider securities officially concludes. This...

Bruker Corporation, a leading manufacturer of analytical instrumentation, faces significant investor skepticism after reporting unexpectedly weak second-quarter 2025 results and...

Shares of BioNano Genomics closed Friday's session at $3.77, marking a modest decline of 2.08%. This slight pullback followed a...